Biohub today announced the release of a world model of protein biology: a scientific engine for prediction, design, and ...
Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...
CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, today launches its first set of muscle cell disease model products designed to advance the discovery and ...
Immorta Bio Inc. has reported new data demonstrating that its combination therapy of Senovax, a first-in-class senolytic immunotherapy, and personalized mesenchymal stem cells (pMSCs) from its ...
The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by redalpine, with the ...
Accurate cancer models are integral to the success of preclinical research yet have proven elusive. Mindy Goldsborough (ATCC, VA, USA) discusses the ongoing efforts to develop improved in vitro models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results